AG
APLT

Algert Global’s Applied Therapeutics APLT Stock Holding History

Algert Global’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-23,476
Closed -$110K – 1189
2024
Q2 		$110K Buy
+23,476
New +$111K ﹤0.01% 1379
2022
Q3 		– Sell
-37,160
Closed -$35K – 1169
2022
Q2 		$35K Buy
37,160
+8,740
+31% +$14.3K ﹤0.01% 1164
2022
Q1 		$60K Buy
+28,420
New +$76.1K ﹤0.01% 1133

Other funds holding APLT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Algert Global's APLT Position: Q3 2024 in Review

Algert Global sold out of Applied Therapeutics (APLT) in Q3 2024, closing a stake of 23,476 shares — an estimated $110K sold.

Algert Global first reported a position in APLT in Q1 2022 and held it in 3 quarters. The position peaked at $110K in Q2 2024. 126 funds tracked by Wall St. Rank hold APLT as of Q3 2024.

  • Algert Global reported no remaining Applied Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Algert Global sold 23,476 Applied Therapeutics shares in Q3 2024, an estimated $110K.
  • Algert Global first reported a position in Applied Therapeutics in Q1 2022 and held it in 3 quarters.
  • Algert Global's Applied Therapeutics position peaked at $110K in Q2 2024.
  • 126 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2024.

Based on Algert Global's 13F filing for Q3 2024, filed 12 Nov 2024.